P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998-2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS.
In: HemaSphere, Jg. 7 (2023-08-01)
Online
academicJournal
Zugriff:
Titel: |
P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998-2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS.
|
---|---|
Autor/in / Beteiligte Person: | Tadmor, Tamar ; Melamed, Guy ; Alapi, Hilel ; Gazit, Sivan ; Patalon, Tal ; Rokach, Lior |
Link: | |
Zeitschrift: | HemaSphere, Jg. 7 (2023-08-01) |
Veröffentlichung: | Wiley, 2023 |
Medientyp: | academicJournal |
ISSN: | 2572-9241 (print) ; 0000-9695 (print) |
DOI: | 10.1097/01.HS9.0000969512.94466.6d |
Schlagwort: |
|
Sonstiges: |
|